Category : Probiotics

It is a well-known fact that caesarean section (c-section) birth is related to an increased risk of both immune and metabolic diseases later in life, possibly through aberrant gut microbiota composition and/or functional diversity. However, little is known about the effect of targeting gut microbiota with prebiotics and probiotics in c-section-born infants. A new randomized, double-blind, controlled multicentre study, led…

GMFH Editing Team
GMFH Editing Team

It is a well-known fact that caesarean section (c-section) birth is related to an increased risk of both immune and metabolic diseases later in life, possibly through aberrant gut microbiota composition and/or functional diversity. However, little is known about the effect of targeting gut microbiota with prebiotics and probiotics in c-section-born infants. A new randomized, double-blind, controlled multicentre study, led…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health publishing team is delighted to share the second summary document on the latest scientific work related to gut microbiota and probiotics! With gastrointestinal (GI) symptoms high in prevalence throughout the world, and with limited available therapeutic options for addressing functional GI disorders, is there a role for probiotics? This document covers human research that elucidates…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health publishing team is delighted to share the second summary document on the latest scientific work related to gut microbiota and probiotics! With gastrointestinal (GI) symptoms high in prevalence throughout the world, and with limited available therapeutic options for addressing functional GI disorders, is there a role for probiotics? This document covers human research that elucidates…

GMFH Editing Team
GMFH Editing Team

Gut-related symptoms, including flatulence, bloating, heartburn, nausea, vomiting, constipation, diarrhoea, food intolerance, incontinence, and abdominal pain affect approximately one third of the general population, according to the World Gastroenterology Organisation. Among the functional gastrointestinal disorders (FGIDs) that are characterized by persistent and recurring GI symptoms, irritable bowel syndrome (IBS) affects around 11% of the population globally and can interfere with…

GMFH Editing Team
GMFH Editing Team

Gut-related symptoms, including flatulence, bloating, heartburn, nausea, vomiting, constipation, diarrhoea, food intolerance, incontinence, and abdominal pain affect approximately one third of the general population, according to the World Gastroenterology Organisation. Among the functional gastrointestinal disorders (FGIDs) that are characterized by persistent and recurring GI symptoms, irritable bowel syndrome (IBS) affects around 11% of the population globally and can interfere with…

GMFH Editing Team
GMFH Editing Team
Canadian Obesity Network

Although plenty of research in both animal models and humans during the last decade has explored the relationship between the gut microbiota and obesity and related metabolic disorders, the clinically relevant contribution of gut microbiota to obesity and related metabolic disorders is still unknown. The relationship between obesity and metabolic diseases has been recently covered in a review article by…

GMFH Editing Team
GMFH Editing Team

Canadian Obesity Network

Although plenty of research in both animal models and humans during the last decade has explored the relationship between the gut microbiota and obesity and related metabolic disorders, the clinically relevant contribution of gut microbiota to obesity and related metabolic disorders is still unknown. The relationship between obesity and metabolic diseases has been recently covered in a review article by…

GMFH Editing Team
GMFH Editing Team

Many questions arise when it comes to probiotics and gut microbiota. By what mechanisms of action can probiotics affect host health? What is the role of probiotics in preventing healthcare-associated infections? Do probiotics affect the intestinal barrier? The Gut Microbiota for Health publishing team has asked a selection of world-leading experts to weigh in on the answers, and we're pleased…

GMFH Editing Team
GMFH Editing Team

Many questions arise when it comes to probiotics and gut microbiota. By what mechanisms of action can probiotics affect host health? What is the role of probiotics in preventing healthcare-associated infections? Do probiotics affect the intestinal barrier? The Gut Microbiota for Health publishing team has asked a selection of world-leading experts to weigh in on the answers, and we're pleased…

GMFH Editing Team
GMFH Editing Team

At the end of 2017, GMFH celebrated its 5th anniversary. As a wrap-up of this celebration, we asked members of our Gut Microbiota for Health board of experts to share their thoughts, on video, about these 5 years in which they contributed toward increased knowledge about the gut microbiota and its role in health, and made the initiative what it’s…

GMFH Editing Team
GMFH Editing Team

At the end of 2017, GMFH celebrated its 5th anniversary. As a wrap-up of this celebration, we asked members of our Gut Microbiota for Health board of experts to share their thoughts, on video, about these 5 years in which they contributed toward increased knowledge about the gut microbiota and its role in health, and made the initiative what it’s…

GMFH Editing Team
GMFH Editing Team

Probiotics have a range of documented effects on human health, with hundreds of studies from the past several decades showing their ability to alter physical or behavioural phenotypes in humans. These human efficacy trials provide the necessary evidence to guide probiotic use. In designing a trial, however, the researchers often wonder how to select the best strain for the task…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Probiotics have a range of documented effects on human health, with hundreds of studies from the past several decades showing their ability to alter physical or behavioural phenotypes in humans. These human efficacy trials provide the necessary evidence to guide probiotic use. In designing a trial, however, the researchers often wonder how to select the best strain for the task…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Awareness of the importance of the gut microbiota and its role in the health has grown in parallel with research on the subject. Over the past five years, Gut Microbiota for Health has contributed to this awareness not only through its website and digital ecosystem, but also through its annual Gut Microbiota for Health World Summit, specifically addressed to clinical…

GMFH Editing Team
GMFH Editing Team

Awareness of the importance of the gut microbiota and its role in the health has grown in parallel with research on the subject. Over the past five years, Gut Microbiota for Health has contributed to this awareness not only through its website and digital ecosystem, but also through its annual Gut Microbiota for Health World Summit, specifically addressed to clinical…

GMFH Editing Team
GMFH Editing Team

It’s already been five years since the Gut Microbiota for Health team came together with a mission to share knowledge about gut microbiota science with scientists, healthcare professionals, and the wider world! In 2012, the European Society of Neurogastroenterology and Motility (member of United European Gastroenterology) created a Gut Microbiota & Health section with a mission to increase recognition of…

GMFH Editing Team
GMFH Editing Team

It’s already been five years since the Gut Microbiota for Health team came together with a mission to share knowledge about gut microbiota science with scientists, healthcare professionals, and the wider world! In 2012, the European Society of Neurogastroenterology and Motility (member of United European Gastroenterology) created a Gut Microbiota & Health section with a mission to increase recognition of…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health (GMFH) digital community was more active in 2017 than in any previous year—with over 50,000 scientists, healthcare professionals, and members of the public now taking part in the online conversation about gut microbiota! The website had over 950,000 visits this year, and was selected once again as one of Healthline's best gut health blogs. Among…

GMFH Editing Team
GMFH Editing Team

The Gut Microbiota for Health (GMFH) digital community was more active in 2017 than in any previous year—with over 50,000 scientists, healthcare professionals, and members of the public now taking part in the online conversation about gut microbiota! The website had over 950,000 visits this year, and was selected once again as one of Healthline's best gut health blogs. Among…

GMFH Editing Team
GMFH Editing Team